Carregant...
FGFR-gerichtete Therapie von Kopf-Hals-Karzinomen
BACKGROUND: Genomic aberrations (mutations, gene fusions, amplifications) and dysregulation of the fibroblast growth factor (FGF) receptor (FGFR) signaling pathway are frequently found in squamous cell carcinomas of the head and neck (HNSCCs). Targeted therapy with tyrosine kinase inhibitors (TKIs)...
Guardat en:
| Publicat a: | HNO |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Medizin
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7902560/ https://ncbi.nlm.nih.gov/pubmed/32519203 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00106-020-00893-2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|